相关实验视频
Updated: Jun 22, 2026

09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
15.5K
针对1型糖尿病的HLAII类四分体试验的技术验证和实用性:一项多中心研究
Ruth A Ettinger1, Mijke Buitinga2, Céline Vandamme3
1Center for Translational Immunology, Benaroya Research Institute, Seattle, WA 98101, USA.
The Journal of clinical endocrinology and metabolism
|July 20, 2023
概括
一种新的四聚体测定精确地测量了特异于糖尿病自身抗原的T细胞,有助于1型糖尿病 (T1D) 风险评估和个性化治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 糖尿病研究 糖尿病研究
- T细胞生物学T细胞生物学
背景情况:
- 针对自身抗原特异性T细胞测量的验证测定对于1型糖尿病 (T1D) 管理至关重要.
- 评估T细胞频率和表型有助于风险分层,疾病监测和治疗评估.
研究的目的:
- 为了技术验证HLA-DRB1*04:01的四聚体测定,这是T1D易感性的关键等位基因.
- 列举和表型T细胞特异性T1D自身抗原和一个参考流感表位.
主要方法:
- 使用单个和多中心测试与尖端样本和T1D患者复制品进行四聚体试验验证.
- 测试应用于横截面T1D队列,以评估临床效用.
- 目标变化系数 (CV) <30%的可重复性.
主要成果:
- 对流感和小岛特异性T细胞实现了可重现的测量,CVs通常在目标范围内.
- 探索性研究揭示了T细胞频率,表型和疾病持续时间和性别等临床因素之间的相关性.
- 很大一部分小岛特异性T细胞表现出一个天真的表型.
结论:
- 经过验证的四聚体试验是可重现的,并且有效地表征小岛特异性T细胞.
- 该试验有助于确定T细胞指标与T1D的临床特征之间的相关性.
- 该工具支持基于抗原的个性化疗法和改进T1D管理.
相关概念视频
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

